EAR-20,一种新的NMDA受体阳性全调节器
Roberto García-Díaz1,2,3, Aida Castellanos1, Federico Miguez-Cabello1
1Neurophysiology Laboratory, Department of Biomedicine, Faculty of Medicine and Health Sciences, Institute of Neurosciences, University of Barcelona, Barcelona, Spain.
Frontiers in pharmacology
|December 8, 2025
概括
一种新型的,EAR-20,作为NMDA受体 (NMDARs) 的正调节器 (PAM). 这种可以增强NMDAR的功能并挽救突变,为神经系统疾病提供潜在的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 基调节器精细调整连接体带离子通道活性,而不会与内源连接体竞争.
- NMDA受体 (NMDARs) 对神经传递和突触可塑性至关重要,这使得它们成为NMDAR低功能障碍的治疗点.
研究的目的:
- 描述EAR-20,一种来自Conantokin-G的,作为NMDARs的新型阳性全调节器 (PAM).
- 研究EAR-20作用机制及其对NMDAR相关疾病的治疗潜力.
主要方法:
- 分子对接以确定结合点.
- 全细胞和单通道补丁的电生理学.
- 在培养的海马神经元中进行记录以评估NMDAR功能.
主要成果:
- EAR-20通过增加通道开放概率和减少无敏化来增强NMDAR功能.
- 它显著增强GluN1-GluN2A和GluN1-GluN2B受体,并增强神经元中的NMDAR电流.
- 分子对接揭示了GluN1-GluN2B接口的结合部位,GluN1中的Ser773是关键的.
- EAR-20部分拯救了具有功能丧失突变的NMDARs.
结论:
- EAR-20是一种新型的,依赖子单位的NMDARs的阳性全调节器.
- 它显示了开发针对神经和神经发育障碍的NMDAR低功能的治疗方法的潜力.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
517
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
517
Ligand-Gated Ion Channel Receptor: Gating Mechanism
3.7K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.7K
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
2.7K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
2.7K
Adrenergic Agonists: Indirect-Acting Agents
2.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.5K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.8K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.8K


